Not FDA-approved

Immune & defense

KPV

Evidence

Lab and animal studies

Class

Tripeptide from alpha-MSH

KEY TAKEAWAY

KPV is a three-amino-acid fragment of alpha-MSH. In lab and animal models it calms inflammation in the gut and skin. It has not been tested in large human trials.

Written by the Veylo editorial team · Updated

November 2026

At a glance

At a glance

What it is

A short peptide from the tail of alpha-MSH

Studied for

Inflammatory bowel disease and skin inflammation

Key fact

Reduced inflammation in animal colitis models; no large human trials

Route

Oral or topical (research use)

Evidence strength

Lab and animal studies

What it is

What it is

KPV is made of the amino acids lysine, proline and valine, the last three residues of alpha-MSH.

How it works

How it works

Lab studies suggest it reduces inflammatory signaling inside cells, including the NF-kB pathway.

Regulatory status

Regulatory status

KPV is not approved by the FDA for any condition.

What it is used for

What it is used for

Studied in animals for colitis and inflammatory skin conditions. It has no approved medical use.

Side effects and risks

Side effects and risks

Human safety data are lacking, so risks are not well defined.

Citations

Citations

Primary literature for this entry is being compiled.

Veylo content is educational and not medical advice. Peptides that are not FDA-approved are not approved for the uses described.

Veylo

Clinician-guided peptide care, paired with baseline blood testing and ongoing support.

Peptides referenced on this site are compounded medications and are investigational; they have not been approved by the FDA for the uses described. Nothing here is medical advice. Prescriptions are issued only after a licensed clinician reviews your history.

© 2026 Veylo. All rights reserved.

Veylo

Veylo

Veylo